002393 力生製藥
按盤價 
17.680 +1.290 (+7.871%)
17.680 +1.290 (+7.871%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.088 | 7.821 | 2.137 | 2.803 | 0.200 |
| 總資產報酬率 ROA (%) | 1.730 | 6.536 | 1.786 | 2.391 | 0.167 |
| 投入資產回報率 ROIC (%) | 1.969 | 7.403 | 2.025 | 2.651 | 0.187 | 邊際利潤分析 |
| 銷售毛利率 (%) | 56.160 | 59.398 | 57.589 | 58.379 | 61.475 |
| 營業利潤率 (%) | 16.216 | 36.409 | 10.297 | 12.538 | 2.720 |
| 息稅前利潤/營業總收入 (%) | 11.217 | 31.270 | 4.449 | 4.579 | 0.287 |
| 淨利潤/營業總收入 (%) | 13.601 | 31.381 | 8.164 | 11.182 | 0.755 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 94.833 | 43.668 | 124.283 | 94.316 | 253.015 |
| 價值變動淨收益/利潤總額(%) | 3.430 | 3.837 | 20.244 | 14.037 | 52.323 |
| 營業外收支淨額/利潤總額(%) | -0.094 | 0.097 | 0.253 | 0.155 | -0.316 | 償債能力分析 |
| 流動比率 (X) | 3.495 | 4.501 | 3.597 | 4.265 | 4.464 |
| 速動比率 (X) | 3.190 | 4.219 | 3.324 | 3.851 | 3.990 |
| 資產負債率 (%) | 18.461 | 15.174 | 17.797 | 15.034 | 0.143 |
| 帶息債務/全部投入資本 (%) | 1.054 | 0.425 | 0.834 | 0.175 | 0.984 |
| 股東權益/帶息債務 (%) | 8,911.462 | 22,287.935 | 11,341.693 | 54,114.921 | 9,574.399 |
| 股東權益/負債合計 (%) | 438.805 | 559.003 | 461.884 | 565.143 | 597.441 |
| 利息保障倍數 (X) | -2.250 | -6.044 | -0.757 | -0.574 | -0.118 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 40.566 | 25.410 | 41.029 | 46.233 | 50.121 |
| 存貨周轉天數 (天) | 120.764 | 144.350 | 158.398 | 184.941 | 211.587 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
